Stanley Riddell

17PUBLICATIONS
137CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Linda Warmuth, Sarah Dötsch, Manuel Trebo

|Mar 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy.

Sylvain Simon, Grace Bugos, Rachel Prins

|Oct 28, 2024
Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies.

Carla A Jaeger-Ruckstuhl, Jennifer M Specht, Jenna M Voutsinas

|Apr 19, 2024
TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.

Simone A Minnie, Olivia G Waltner, Ping Zhang

|Sep 29, 2023
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.

Emily C Liang, Aya Albittar, Jennifer J Huang

|Jul 17, 2023
Stem-cell-like CD4+ T cells prey on MHC class II-negative tumors.

Joshua R Veatch, Stanley R Riddell

Pageof 3

Frequent Collaborators

5 joint publications

David G Maloney

5 joint publications

Cameron J Turtle

4 joint publications

Alexandre V Hirayama

4 joint publications

Alexander I Salter